J&J | JNJ - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
AbbVie USD 12.48B 110M 2026-03
Abbott USD 11.22B 655M 2026-03
Amgen USD 10.23B 1.09B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Baxter International USD 1.86B 158M 2026-06
Bayer EUR 18.55B 4.36B 2026-03
Becton, Dickinson and Co. USD 2.36B 159M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Boston Scientific USD 3.03B 101M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
CONMED USD 239.77M 11.11M 2026-06
Cooper Companies USD 809.2M 2.1M 2026-03
Dexcom USD 1.27B 175.4M 2026-06
Edwards Lifesciences USD 973M 60.9M 2026-03
Eli Lilly USD 23.48B 2.3B 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Globus Medical USD 739.28M 3.84M 2026-06
Insulet USD 588.7M 44M 2026-06
Integra LifeSciences USD 267.19M 2.78M 2026-06
Intuitive Surgical USD 1.67B 77.6M 2026-06
J&J USD 22.54B 1.21B 2026-03
Medtronic USD 6.36B 30M 2025-12
Merck USD 12.21B 435M 2026-03
Merit Medical Systems USD 250.9M 23.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 492M 10M 2026-06
Stryker USD 3.74B 172M 2026-06
Tandem Diabetes Care USD 162.06M 21.39M 2026-06
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Zimmer Biomet Holdings USD 1.77B 40.9M 2026-06
Zoetis USD 1.57B 65M 2026-06